Showing results (991-1000 of 1,782) with videos related to

Sort By:
Pageof 179
Omega|February 13, 2003
Psychosocial versus biomedical risk factors in Kevorkian's first forty-seven physician-assisted deathsK J Kaplan, F Lachenmeier, M Harrow, et al.
Journal of Surgical Oncology|December 4, 2019
Simplified preoperative tool predicting discharge destination after major oncologic gastrointestinal surgeryRajesh Ramanathan, Caroline Rieser, Saba Kurtom, et al.
Disease Models & Mechanisms|August 3, 2016
Alterations in nuclear structure promote lupus autoimmunity in a mouse modelNamrata Singh, Duncan B Johnstone, Kayla A Martin, et al.
The Neurohospitalist|June 27, 2022
Web Browsing: High-Speed Diagnosis and Treatment of Carotid Artery WebCharles DeMello Schutt, Jorge J Pesquera, Swetha Renati, et al.
Ophtalmologie : Organe De La Societe Francaise D'Ophtalmologie|June 1, 1989
[Associated forms of hereditary chorioretinal degeneration]N Manderieux, J L Dufier, J Kaplan, et al.
Investigative Ophthalmology & Visual Science|August 29, 2007
Endogenous bone marrow derived cells express retinal pigment epithelium cell markers and migrate to focal areas of RPE damageYang Li, Pelin Atmaca-Sonmez, Carrie L Schanie, et al.
Ocular Immunology and Inflammation|March 17, 2007
Targeting tissue factor for immunotherapy of choroidal neovascularization by intravitreal delivery of factor VII-Fc chimeric antibodyTongalp H Tezel, Ewa Bodek, Kenan Sönmez, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 2010
The detrimental effects of IFN-α on vasculogenesis in lupus are mediated by repression of IL-1 pathways: potential role in atherogenesis and renal vascular rarefactionSeth G Thacker, Celine C Berthier, Deborah Mattinzoli, et al.
Investigative Ophthalmology & Visual Science|March 28, 2006
Blockade of the interaction of leukotriene b4 with its receptor prevents development of autoimmune uveitisTianjiang Liao, Yan Ke, Wen-Hai Shao, et al.
Clinical Immunology (Orlando, Fla.)|August 22, 2013
The peroxisome-proliferator activated receptor-γ agonist pioglitazone modulates aberrant T cell responses in systemic lupus erythematosusWenpu Zhao, Celine C Berthier, Emily E Lewis, et al.
Pageof 179